hepatitis b/seizures

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 70 rezilta yo

Cerebral atrophy and convulsive seizures after recovery from cerebral edema and coma in a patient with fulminant hepatitis B.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We report a 48-year-old woman who developed convulsive seizures and cerebral atrophy after recovery from fulminant hepatitis B with coma and cerebral edema at the acute stage. Neurological disturbances and cerebral signs are rare sequelae of fulminant hepatic failure (FHF); only a few cases have

Afebrile convulsion in an adult after recombinant hepatitis B vaccination.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Vaccination against HBV is important in order to reduce the incidence of HBV infection. Although the HBV vaccine is among the safest of all vaccines, vaccination against HBV has been associated with side-effects. Herein we present a case of afebrile convulsion after recombinant HBV vaccination.

Viral hepatitis type B presenting with seizure.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Convulsion associated with fever following hepatitis B vaccination.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Interferon (IFN) is the most widely prescribed drug of choice for chronic hepatitis B infection, which is a common health problem in our country. Therapy with IFN-alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders.

Safety of neonatal hepatitis B vaccine administration.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To determine whether hepatitis B vaccination of newborns increases the incidence of fever and/or suspected sepsis. METHODS A prospective clinical study was undertaken at the Kaiser Permanente San Francisco Medical Center involving normal full term newborns born between November 1, 1991,

Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The case reported refers to a patient who developed status epilepticus in the day of her third dose of hepatitis B vaccination and we review the literature on this subject. A 12 year-old girl, without a relevant previous history, taking no drugs, developed a seizure attack followed by

Temporary heterotopic auxiliary liver transplantation for fulminant hepatitis B.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Orthotopic liver transplantation has been shown to improve survival in fulminant hepatic failure. However, after orthotopic liver transplantation life-long immunosuppression is necessary and graft complications may occur. METHODS We employed heterotopic auxiliary liver transplantation in a

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Prelicensure studies of diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus vaccine suggested that there were higher rates of fever after its administration than when its component antigens were given separately. METHODS We conducted an open, controlled, cohort

[A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination?].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Several reports of new cases of CNS demyelination or reactivation of MS after hepatitis B vaccination have raised the possibility of a causal relationship. Conversely, some authors have concluded that the risk of developing a demyelinating CNS event after a hepatitis B vaccination is

Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In 1982, the Centers for Disease Control, the Food and Drug Administration, and the manufacturer created a surveillance system to monitor spontaneous reports of adverse events occurring after inoculation with the new plasma-derived hepatitis B vaccine (Heptavax-B, Merck Sharp and Dohme, West Point,

Intracranial hemorrhage induced uncontrolled seizure in a deceased donor liver transplant patient: a case report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Seizure is the second most common neurologic complication after liver transplantation and may be caused by metabolic abnormalities, electrolyte imbalance, infection, and immunosuppressant toxicity. A 61-year-old male patient underwent liver transplantation due to hepatitis B virus-related liver

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In an uncontrolled trial, 29 patients with chronic hepatitis B virus infection were treated with 93 courses of adenine arabinoside at doses ranging from 2.5 to 15 mg/kg per day. Most patients were treated concomitantly with human leukocyte interferon. Significant, but transient, neurotoxicity was

[Vaccinal status in children with seizures: a retrospective study conducted in the Bordeaux child hospital].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Vaccination is a common act in medicine. Some serious side effects are always feared in a preventive action, mainly among high-risk patients such as epileptic children or children having already experienced a seizure. OBJECTIVE To study consequences of such background on the vaccine medical

Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The aim of this study was to assess morbidity and the incidence of adverse effects during interferon (IFN)-alpha-2a treatment of patients with chronic hepatitis B. This prospective study included 48 consecutive patients with chronic hepatitis B who underwent IFN-alpha-2a treatment from January 2003

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye